Petitioner: DEPARTMENT OF HEALTH
Respondent: CORAL WEST PHARMACY, INC., D/B/A WESTCHESTER PHARMACY
Judges: EDWARD T. BAUER
Agency: Department of Health
Locations: Miami, Florida
Filed: Aug. 09, 2011
Status: Closed
Settled and/or Dismissed prior to entry of RO/FO on Monday, December 10, 2012.
Latest Update: Dec. 24, 2024
STATE OF FLORIDA
DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH,
PETITIONER,
Vv. CASE NO.: 2011-09924
CORAL WEST PHARMACY, INC,,
d/b/a WESTCHESTER PHARMACY,
RESPONDENT.
/
DMIN IVE P
Petitioner Department of Health (“Department”) files _ this
Administrative Complaint before the Board of Pharmacy against Coral West
Pharmacy, Inc., d/b/a Westchester Pharmacy (“Coral West” or the
“Pharmacy”), and in support thereof alleges:
1. The Department Is the state agency charged with regulating
pharmacies in Florida, pursuant to Chapters 20, 456 and 465, Florida
Statutes (2010). .
2. At all times material to this Order, Coral West was licensed to
_ Operate as a pharmacy in the State of Florida pursuant to Chapter 465,
Florida Statutes.
Filed August 9, 2011 4:34 PM Division of Administrative Hearings
DOH v, Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No. 2011-09924
3. On January 13, 2011, an undercover Investigator (‘UC”) from
the Florida Attorney General’s Medicaid Fraud Control Unit (“MFCU”) and a
confidential informant (“CI’)' presented to Coral West as Medicaid
recipients seeking to sell prescriptions? to Coral West.
4. Once within the Pharmacy, UC and CA met with the Pharmacy’s
registered technician (the “R.T.”), who asked CI to identify which
prescriptions he wanted filled and which ones he wanted to sell. CI
advised the R.T. that he wanted to sell his prescriptions for Prevacid and
Crestor and that he wanted his remaining prescriptions? filled.
5. Prevacid belongs to a class of antisecretory compounds and is
used to suppress gastric acid secretion. Crestor is a synthetic lipid-
lowering agent.
1 Before becoming @ confidential Informant for MFCU, CI routinely sold prescriptions to Coral West,
2 CI had previously provided Cora! West with paper prescriptions for these medications and, during this visit, sought a refill of the
medications.
Cl’s remaining prescriptions were for Temazepam, Lisinopril, Alprazolam, Metropoto!, Digoxin and Furosemide. Temazepam
contains benzodiazepine and Is prescribed for the short-term treatment of sleeplessness In patients who have difficulty maintaining
sleep, According to Section 893,03(4), Florida Statutes, Temazepam Is a Schedule 1V controlled substance that has a low potential
for abuse relative to the substances in Schedule III and has a currently accepted medical use in treatment In the United States,
Abuse of Temazepam may tead to limited physical or psycholagical dependence relative to the substances In Schedule IIT, Lsinoprit
Is an anglotensin-converting enzyme (ACE) inhibitor that Is primarily used in weatment of hypertension, congestive heart fallure,
and heart attacks and also In preventing rena! and retinal complications of diabetes. Alprazolam (brand name Xanax,
benzodiazepine) is prescribed to treat anxiety. According to Section 893,03(4), Florida Statutes, alprazolam Is-@ Schedule 1V
controfled substance that has a low potential for abuse relative to the substances in Schedule IIT and has a currently accepted
medical use in treatment In the United States. Abuse of alprazolam may tead to Smited physical or psychological dependence
relative to the substances In Schedule TI], Metropoto! is a selective Bi; receptor blocker used in treatment of several diseases of the
cardiovascular system, especially hypertension. Digoxin is indicated for the treatment of various heart conditions, namely atrial
fibrillation, atrial flutter and sometimes heart fallure that cannot be controlled by other medication, Furosemide Is a loop diuretic
used in the treatment of congestive heart fallure and edema.
DOH v. Coral West Pharmacy, Inc,,
d/b/a Westchester Pharmacy
Case No, 2011-09924
6. At the conclusion of this visit, Coral West provided CI with an
envelope containing $30.00 for the Prevacid prescription and $30.00 for
the Crestor prescription. Following this visit, Coral West billed, and
received payment from, the Medicaid Program for the Crestor and Prevacid
prescriptions presented by CI that were never filled or dispensed by the ©
Pharmacy. In addition, Coral West billed, and received payment from, the
Medicaid Program for a Plavix prescription that CI did not present to Coral
_ West and that was never filled or dispensed by the Pharmacy. In total,
Coral West collected payment from the Medicaid Program in the amount of
$453.91 for purportedly filling the Plavix, Crestor and Prevacid prescriptions
presented by CI.
7. Plavix is the brand name for clopidogrel, an antiplatelet agent
used to inhibit blood clots.
8. On or about January 20, 2011, CI dropped off prescriptions for
Lidoderm and Abilify at Coral West for the purpose of selling the
prescriptions to the Pharmacy. According to a prior arrangement between
CI and the R.T., CI was to be paid $50.00 for each Abilify prescription and
$30.00 for each Lidoderm prescription sold to Coral West.
DOH v. Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No. 2011-09924
9, Abilify is an atypical antipsychotic and antidepressant used in
the treatment of schizophrenia, bipolar disorder and clinical depression.
10. Lidoderm is an adhesive patch that contains lidocaine, a local
anesthetic that may lead to severe toxicity or death in both children and
adults if used Improperly.
11. On January 27, 2011, CI and UC presented to Coral West to
collect payment on the Abilify and Lidoderm prescriptions CI had previously
delivered to the Pharmacy. At the conclusion of this visit, Coral West made
payment to CI in the amount of $50.00 for the Abilify prescription and
$30.00 for the Lidoderm prescription. After this visit, Coral West collected
payment from the Medicaid Program in the amount of $688.01 for the
Abilify and Lidoderm prescriptions presented by CI, neither of which was
ever actually filled.
12. On or about February 15, 2011, CI and UC presented to Coral
West in order to sell Cl’s prescriptions for Prevacid, Plavix and Abilify to the
Pharmacy. CI presented hardcopy prescriptions for Prevacid and Plavix
and refill prescriptions for several other medications’, Including Abilify and
‘The other refill prescriptions presented by CI were for medications that Included Alprazolam, Furosemide, Metropolol, Lisinopril,
Olgoxin, Nitrostat, Carvedilol and Temazepam, Nitrostat contains nitraglycerin, which is used medically as a vasodilator to treat
heart conditions, such as angina and chronic heart fallure. Carvedito! Is a non-selective beta blocker/alpha-1 blocker indicated in
the treatment of nilld to moderate congestive heart fallure,
DOH v, Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No, 2011-09924
Crestor, to the Pharmacy. During this visit, the R.T. advised CI and UC
that Coral West would make payment to CI for the prescriptions presented
that day on a later date.
13. On February 22, 2011, CI and UC returned to Coral West. The
R.T. made payment to CI for the Abilify, Prevacid, Plavix and Crestor
| prescriptions presented by CI on February 17, 2011, In the amount of
$60.00 for the Abilify prescription, $30.00 for the Prevacid prescription,
$30.00 for the Plavix prescription and $30.00 for the Crestor prescription,
_ for a total of $150.00. -Coral West subsequently billed, and recelved
payment from, Medicald in the amount of $960.64 for the four
prescriptions, none of which was filled by the Pharmacy.
14. On March 15, 2011, CI presented to Coral West with refill
prescriptions for Carvedilol, Spironolactone, Temazepam, Metropoiol,
Lisinopril, Furosemide, Digoxin, Alprazolam, Aspirin, Crestor, Prevactd,
Abilify and Plavix. Spironolactone Is a diuretic used primarily to treat heart
failure
15. As with prior visits, CI identified those prescriptions he wanted
filled and those he wanted to sell. At the conclusion of this visit, CI
received payment from Coral West In the amount of $140.00 for his
DOH v. Coral West Pharmacy, Inc.,
d/o/a Westchester Pharmacy
Case No, 2011-09924
Crestor, Prevacid, Abilify and Plavix prescriptions. Subsequently, Coral
West billed, and received payment from, Medicaid in the amount of
$1,012.27 for the Crestor, Prevacid, Abilify and Plavix prescriptions, none
of which was filled by the Pharmacy.
- 16. On April 14, 2011, CI and UC again presented at Coral West.
CI and UC had previously dropped off prescriptions for Lidoderm, Crestor,
Plavix, Abilify, Prevacid, Digoxin, Lisinopril, Aspirin, Metropolol, Furosemide,
Carvedilol and Spironolactone at Coral West and were returning to pick up
the medications that were to be filled and to collect payment on those that
were being: sold to the Pharmacy. During this visit, CI identified those
prescriptions he wanted to sell to the Pharmacy and those he wanted to be
filled, At the conclusion. of this visit, Coral -West made payment to CI in the
amount of $140.00 for his prescriptions for Crestor, Prevacid, Abilify and
Plavix, none of which was filled by Coral West. Coral West subsequently
billed, and received payment from, Medicaid in the amount of $1,196.10
for the Lidgderm®, Crestor, Prevacid, Abilify and Plavix prescriptions, none
of which was filled by the pharmacy. CI’s remaining prescriptions were
filled by the Pharmacy. During the course of this visit, CI also sold seven
5 Coral west neither filled, nor paid CI for, the Lidoderm prescription.
DOH v, Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No. 2011-09924
boxes of Lidoderm patches he obtained from a third party® to the
Pharmacy for $190.00.
17, On May 12, 2011, CI and UC returned to Coral West to pick up
medications and collect payment in connection with prescriptions CI had
previously dropped off at the Pharmacy. A short time later, Coral West's
pharmacist dispensed the following medications to CI: Alprazolam,
Furosemide, Temazepam, Digoxin, Lisinopril, Amlodipine Besylate,
Splronolactone, Carvedilol and Aspirin. Amlodipine Besylate is a long-
acting calclum channel blocker ‘(dihydropyridine class) used as an anti-
hypertensive and In the treatment of angina.
18. Later this visit, Coral West made payment to CI in the amount
of $140.00 for his prescriptions for Crestor, Prevacid, Abilify and Plavix,
none of which was filled by Coral West. Coral West subsequently billed, .
and received payment from, Medicaid in the amount of $1,196.10 for the
Lidoderm’, Crestor, Prevacid, Abilify and Plavix prescriptions, none of which .
was filled by the Pharmacy.
§ This person was a customer of the Pharmacy and was not authorized to
distribute prescription drugs.
1 coral West neither filled, nor paid CI for, the Lidoderm prescription.
DOH vy, Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No, 2011-09924
19. On June 9, 2011, Department investigators performed an
inspection of Coral West. During the course. of their inspection, the
Department's investigators determined that Coral West was not safe to
operate as a pharmacy because (1) there were no pedigree documents
identifying the source of many of the medications being held in the
Pharmacy’s Inventory; (2) medications bearing labels from other
pharmacies were being held In Coral West’s Inventory; and (3) multiple
bottles of medications without labels were being held In the Pharmacy’s
inventory.
~ COUNT I
20. The Department realleages and incorporates paragraphs 1
through 19 above as if fully set forth herein.
21, Section 465.016(1)(1), Florida Statutes (2010), subjects a
pharmacy to discipline for placing in its stock any part of any prescription
compounded or dispensed which has been returned by a patient.
22. Coral West violated Section 465.016(1)(I), Florida Statutes
(2010), by placing In its stock parts of prescriptions compounded or
dispensed which were returned by patients.
COUNT Il
DOH v. Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No, 2011-09924
23. The Department realleages and incorporates paragraphs 1
| through 19 above as if fully set forth herein.
24. Section 465.016(1)(r), Florida Statutes (2010), subjects a
_ pharmacy to discipline for violating any provision of Chapters 465 or 456,
Florida Statutes (2010), or any rules adopted pursuant thereto, Section
456.072(1)(m), Florida Statutes (2010), subjects licensees, including
pharmacies, to discipline for making deceptive, untrue, or fraudulent
representations in or related to the practice of a profession or employing a
trick or scheme in or related to the practice of a profession.
25. Coral West violated Section 456.072(1)(m), Florida Statutes
(2010), by billing the Medicaid Program for filling prescriptions it did not
actually fill. By violating Section 456.072(1)(m), Florida Statutes (2010),
Coral West also violated Section 465.016(1)(r), Florida Statutes (2010).
OUNT Ti
26. The Department realleages and Incorporates paragraphs 1
through 19 above as if fully set forth herein.
27. Section 465.023(1)(c), Florida Statutes (2010), subjects a
pharmacy to discipline for violating any of the requirements of Chapter
499, Florida Statutes. Section 499.005, Florida Statutes (2010), prohibits,
DOH v, Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No, 2011-09924
in relevant part, the holding or offering for sale of any drug that is
adulterated, the receipt of any drug that is adulterated and the failure to
acquire a pedigree paper in connection with the purchase of a prescription
drug. According to Section 499.006, Florida Statutes (2010), a drug is
adulterated if it is a prescription drug for which the required. pedigree
paper is nonexistent, fraudulent, or incomplete under the requirements of
this part or applicable rules, or that has been purchased, held, sold, or
distributed at any time by a person not authorized under federal or state
law to do so, .
28. Coral West violated Section 499.005, Florida Statutes (2010),
by purchasing and holding prescription drugs that were adulterated and by
failing to have pedigree papers for prescription drugs in its inventory. By
violating Section 499.005, Florida Statutes (2010), Coral West also violated
Section 465.023(1)(c), Florida Statutes (2010).
WHEREFORE, the Department respectfully requests the Board of
Pharmacy enter an order imposing one or more of the following penalties
against Coral West's license to operate as a pharmacy: permanent
revocation or suspension, restriction of practice, administrative fine,
DOH v. Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No. 2011-09924
reprimand, probation, corrective action, refund of fees billed or collected,
remedial education and any other relief the Board deems appropriate.
we
SIGNED this_ 2/0 dayof__ | JULY , 2011.
H. Frank Farmer, Jr., M.D., Ph.D.
. State Surgeon General
fr
anlel Hernandez, Chief Legal Counsel!
FILED Florida Bar No. 176834 PHN O04ZISS
DEPARTMENT OF HEALTH DOH Prosecution Services Unit
4052:Bald Cypress Way, Bin C-65
CLERKNT ILA, Tinie, Tallahassee, FL 32399-3265
pare XX -20( soy 245-4640
(850) 245-4681 FAX
PCP: alocefoo" |
PCP Members: (LAZEr , Risch
DOH v, Coral West Pharmacy, Inc.,
d/b/a Westchester Pharmacy
Case No. 2011-09924
T. F HT.
' Respondent has the right to request a hearing to be
conducted in accordance with Section 120.569 and 120.57,
Florida Statutes, to be represented by counsel or other qualified
representative, to present evidence and argument, to call and
cross-examine witnesses and to have subpoena and subpoena
duces tecum issued on his or her behalf if a hearing is requested. -
E ARDI E
Respondent is placed on notice that Petitioner has incurred
costs related to the investigation and prosecution of this matter.
Pursuant to Section 456.072(4), Florida Statutes, the Board shall
assess costs related to the investigation: and prosecution of a
‘disciplinary matter, which may include attorney hours and costs,
on the Respondent in addition any other discipline imposed.
12
Docket for Case No: 11-003994
Issue Date |
Proceedings |
Dec. 10, 2012 |
Order Closing File and Relinquishing Jurisdiction. CASE CLOSED.
|
Dec. 03, 2012 |
Notice of Withdrawal as Legal Counsel to Respondent filed.
|
Sep. 05, 2012 |
Order Continuing Case in Abeyance (parties to advise status by December 4, 2012).
|
Aug. 31, 2012 |
Joint Status Report filed.
|
Jun. 07, 2012 |
Order Continuing Case in Abeyance (parties to advise status by September 4, 2012).
|
Jun. 06, 2012 |
Joint Status Report filed.
|
Apr. 10, 2012 |
Order Continuing Case in Abeyance (parties to advise status by June 6, 2012).
|
Apr. 03, 2012 |
Joint Status Report filed.
|
Feb. 07, 2012 |
Order Continuing Case in Abeyance (parties to advise status by April 6, 2012).
|
Feb. 06, 2012 |
Joint Status Report filed.
|
Dec. 01, 2011 |
Order Continuing Case in Abeyance (parties to advise status by February 3, 2012).
|
Dec. 01, 2011 |
Joint Status Report filed.
|
Oct. 04, 2011 |
Notice of Cancelling Depositions (of N. Batista) filed.
|
Oct. 03, 2011 |
Notice of Cancelling Depositions (of G. Parra) filed.
|
Oct. 03, 2011 |
Notice of Cancelling Depositions (of S. Bolanos) filed.
|
Oct. 03, 2011 |
Notice of Cancelling Depositions (of Y. Suarez) filed.
|
Oct. 03, 2011 |
Subpoena Ad Testificandum (to S. Bolanos) filed.
|
Oct. 03, 2011 |
Notice of Taking Deposition (of N. Baptista) filed.
|
Oct. 03, 2011 |
Notice of Cancellation of Depositions (of Coral West Pharmacy) filed.
|
Oct. 03, 2011 |
Order Canceling Hearing and Placing Case in Abeyance (parties to advise status by December 2, 2011).
|
Oct. 03, 2011 |
Notice of Cancellation of Depositions (of D. Gross) filed.
|
Sep. 29, 2011 |
Agreed Motion to Hold Case in Abeyance filed.
|
Sep. 27, 2011 |
Order on Motion for Protective Order.
|
Sep. 26, 2011 |
Notice of Serving Petitioner's Answers to Respondent's First Set of Interrogatories, Respondent's First Request for Admissions, Respondent's First Request for Production, and Respondent's Supplemental First Set of Interrogatories to Petitioner filed.
|
Sep. 23, 2011 |
Order Granting Extension of Time to Respond to Discovery Requests.
|
Sep. 22, 2011 |
Unopposed Motion for Extension of Time to Respond to Discovery Requests filed.
|
Sep. 21, 2011 |
Notice of Taking Deposition (of Y. Suarez) filed.
|
Sep. 21, 2011 |
Notice of Taking Deposition (of N. Batista) filed.
|
Sep. 21, 2011 |
Notice of Taking Deposition (of G. Parra) filed.
|
Sep. 21, 2011 |
Notice of Taking Deposition (of D. Gross) filed.
|
Sep. 21, 2011 |
Notice of Taking Deposition (of S. Bolanos) filed.
|
Sep. 21, 2011 |
Notice of Taking Deposition Duces Tecum (of Coral West Pharmacy) filed.
|
Sep. 16, 2011 |
Respondent's Response to Emergency Motion for Protective Order filed.
|
Sep. 16, 2011 |
Order Granting Extension of Time to Reply to Petitioner`s Emergency Motion for Protective Order.
|
Sep. 15, 2011 |
Respondent's Agreed Motion for Extension of Time to Reply to Petitioner's Emergency Motion for Protective Order filed.
|
Sep. 09, 2011 |
Respondent's Notice of Opposition to Petitioner's Emergency Motion for Protective Order filed.
|
Sep. 08, 2011 |
Petitioner's Emergency Motion for Protective Order filed.
|
Aug. 30, 2011 |
Notice of Serving Petitioner's First Request for Production, First Request for Interrogatories and First Request for Admissions to Respondent filed.
|
Aug. 26, 2011 |
Respondent's Supplemental First Set of Interrogatories to Petitioner filed.
|
Aug. 23, 2011 |
Order Denying Motion to Dismiss Administrative Complaint.
|
Aug. 23, 2011 |
Respondent's First Request for Admissions to Petitioner filed.
|
Aug. 23, 2011 |
Respondent's First Request for Production to Petitioner (incomplete) filed.
|
Aug. 23, 2011 |
Respondent's First Set of Interrogatories to Petitioner filed.
|
Aug. 22, 2011 |
Petitioner's Response to Respondent's Motion to Dismiss filed.
|
Aug. 18, 2011 |
Respondent's Motion to Dismiss Administrative Complaint filed.
|
Aug. 17, 2011 |
Order of Pre-hearing Instructions.
|
Aug. 17, 2011 |
Notice of Hearing by Video Teleconference (hearing set for October 31 and November 1, 2011; 9:00 a.m.; Miami and Tallahassee, FL).
|
Aug. 15, 2011 |
Response to Initial Order filed.
|
Aug. 11, 2011 |
Initial Order.
|
Aug. 09, 2011 |
Agency referral filed.
|
Aug. 09, 2011 |
Petition for Formal Administrative Hearing filed.
|
Aug. 09, 2011 |
Administrative Complaint filed.
|